Abstract
Paclitaxel (Taxol®) is a highly praised anticancer drug, known for its efficiency in treating different cancers. It belongs to a class of compounds called taxanes that are derived from the plants of the genus Taxus. This drug is now FDA approved, but there was a time when the name Taxol was less known to the scientific world. Taxol, being a unique molecule in its structure, properties and mechanism of action, has undergone more than 30 years of trials, and faced a lot of hurdles to leave the bench of a laboratory and reach the shelves of a pharmacy. This review focuses on the story of Taxol, how it began and how it achieved the status of Paclitaxel.
DOI
10.35691/JBM.5102.0038
Recommended Citation
Junjua, M.,
Jafar, S.,
Karamat, F.,
& Ahmed, F.
(2015).
From Lab to Pharmacy Shelves: The Story of a Plant Derived Anticancer Drug, "Paclitaxel",
Journal of Bioresource Management, 2
(4).
DOI: 10.35691/JBM.5102.0038
